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Abstract Ring-forming AAA+ chaperones exert ATP-fueled substrate unfolding by threading
through a central pore. This activity is potentially harmful requiring mechanisms for tight repression
and substrate-specific activation. The AAA+ chaperone ClpC with the peptidase ClpP forms a
bacterial protease essential to virulence and stress resistance. The adaptor MecA activates ClpC by
targeting substrates and stimulating ClpC ATPase activity. We show how ClpC is repressed in its
ground state by determining ClpC cryo-EM structures with and without MecA. ClpC forms large
two-helical assemblies that associate via head-to-head contacts between coiled-coil middle domains
(MDs). MecA converts this resting state to an active planar ring structure by binding to MD
interaction sites. Loss of ClpC repression in MD mutants causes constitutive activation and severe
cellular toxicity. These findings unravel an unexpected regulatory concept executed by coiled-coil
MDs to tightly control AAA+ chaperone activity.
DOI: https://doi.org/10.7554/eLife.30120.001
Introduction
AAA+ (ATPase associated with a variety of cellular activities) proteins control a multitude of essential
cellular activities by converting the energy derived from ATP hydrolysis into a mechanical force to
remodel bound substrates (Hanson and Whiteheart, 2005). They are key players in protein quality
control by targeting misfolded and aggregated proteins to degrading and refolding pathways.
ClpB/Hsp104 reactivates aggregated proteins in concert with a cognate Hsp70 system (Doyle et al.,
2013; Mogk et al., 2015). Other AAA+ proteins (e.g. ClpX, Rpt1-6) associate with peptidases (e.g.
ClpP, 20S proteasome) to form AAA+ proteases, feeding protein substrates into associated proteo-
lytic chambers for degradation (Collins and Goldberg, 2017; Baker and Sauer, 2012). The unfold-
ing activity of AAA+ proteins can, however, also be deleterious to cells, in particular if linked to
protein degradation, and therefore needs to be tightly controlled. Accordingly, loss of the control
mechanisms of AAA+ protein activity in mutant proteins can lead to cell death (Oguchi et al., 2012;
Schirmer et al., 2004; Lipin´ska et al., 2013). Controlling substrate selectivity and AAA+ protein
activity is therefore crucial to prevent deleterious activities. This task is frequently executed by
adapter proteins that select substrates but can also regulate the ATPase activity of AAA+ proteins
and couple substrate delivery to ATPase activation (Oguchi et al., 2012; Schlothauer et al., 2003).
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Activity control and adaptor action requires the ATPase activity to be repressed in the ground
state, which is key to AAA+ chaperone mode of action. Repression can be achieved by regulatory
coiled-coil domains inserted into an AAA module. In the ClpB/Hsp104 disaggregase a long coiled-
coil middle domain (MD), consisting of two wings, is forming a repressing belt around the AAA ring
to reduce ATPase activity (Carroni et al., 2014; Heuck et al., 2016). Adjacent MDs bind to each
other by head-to-tail interactions keeping the regulatory domains in place. ATPase repression is
relieved by MD dissociation and binding to Hsp70 adaptors that prevent reassociation of MDs with
the ClpB/Hsp104 ring (Oguchi et al., 2012; Rosenzweig et al., 2013; Lee et al., 2013).
The bacterial AAA+ chaperone ClpC associates with the peptidase ClpP to form a central proteo-
lytic machinery of Gram-positive bacteria. The ClpC-ClpP machinery acts in regulatory and general
proteolysis, controlling multiple cellular pathways and differentiation processes and is crucial for bac-
terial stress resistance and virulence (Turgay et al., 1997; Frees et al., 2014; Trentini et al., 2016;
Capestany et al., 2008; Msadek et al., 1994; Kru¨ger et al., 1994; Kru¨ger et al., 2000;
Lourdault et al., 2011). ClpC activity crucially relies on cooperation with adaptor proteins including
MecA, that target specific substrates while concurrently stimulating ClpC ATPase activity
(Schlothauer et al., 2003; Turgay et al., 1997; Mei et al., 2009; Turgay et al., 1998). MecA binds
to N-terminal and middle domains of each ClpC subunit forming a separate layer on top of the ClpC
AAA ring (Wang et al., 2011). How ClpC is kept inactive in adaptor absence, and how the adaptor
activates the ATPase is largely unknown. Furthermore, ClpC harbors a coiled-coil MD consisting only
of a single wing, as opposed to the two-wing MD of ClpB/Hsp104. A potential regulatory function
of the ClpC MD has not been investigated, but its smaller size as compared to the ClpB/Hsp104 MD
implies it must act differently if involved in ClpC activity control. Understanding ClpC regulation is
particularly relevant as AAA+ protease machines including ClpC have attracted considerable atten-
tion as targets for antibacterial action in recent years (Bro¨tz-Oesterhelt and Sass, 2014). Overruling
eLife digest If a protein does not fold into the correct shape, it may be unable to act correctly
and can harm cells. As a result, cells contain biological machines that refold or break down
misfolded proteins. ATP-dependent AAA+ proteases are an example of such machines. Their
activity needs to be tightly controlled because breaking down the wrong proteins can also harm
cells.
ATP-dependent AAA+ proteases form ring-shaped assemblies that are composed of AAA+
proteins and an associated peptidase. In bacteria, the AAA+ protein called ClpC can be crucial for
resisting stress and infecting host cells. Adapter proteins help to activate ClpC by binding to extra
domains that are fused to or inserted into the protein. This method of activation also requires
repressing elements that ensure that the activity of ClpC remains low when the adapter proteins are
not present. It was not known how this repression works.
Carroni, Franke et al. have now used a technique called cryo-electron microscopy to study the
structures of repressed and adapter-activated ClpC from pathogenic bacteria called Staphylococcus
aureus. In the repressed state, 10 molecules of ClpC interact to form two assemblies that interact via
regions called middle domains. The middle domains have a “coiled coil” structure, and they interact
via their ends in a head-to-head manner. In the repressed state ClpC cannot interact with its partner
peptidase and the shape of the assembly shields the sites where adapter proteins can bind. This
renders ClpC inactive.
Carroni, Franke et al. also studied ClpC proteins that had mutations to the middle domain that
prevented the repressed state from forming. The mutant proteins remain in a constantly active state
that is highly toxic to bacteria.
Bacteria are increasingly evolving to resist the effects of the antibiotics commonly used to treat
infections. This is a severe problem, and we need to develop new antibiotic drugs that will kill these
bacteria. AAA+ proteases have been identified as possible targets for new antibacterial drugs. The
results presented by Carroni, Franke et al. suggest that disrupting the repressing activity of ClpC
middle domains could be an effective way for such drugs to work.
DOI: https://doi.org/10.7554/eLife.30120.002
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AAA+ protease control by small molecules can lead to constitutive uncontrolled and toxic activation
as best exemplified by acyldepsipeptide antibiotics of the ADEP class targeting the ClpP peptidase.
ADEP-activated ClpP causes aberrant protein degradation and even allows for eradication of Staph-
ylococcus aureus persister cells (Conlon et al., 2013; Bro¨tz-Oesterhelt et al., 2005; Kirstein et al.,
2009). Understanding ClpC activity control therefore might open new avenues for antibiotics
development.
Here, we report on an unexpected mode of AAA+ chaperone control involving transition
between an inactive resting state and a functional hexamer as revealed by determining the cryoEM-
structures of S. aureus ClpC in absence and presence of MecA. The ClpC resting state is composed
of two helical ClpC assemblies stabilized by head-to-head MD interactions. MecA prevents MD inter-
actions and thereby converts ClpC into a canonical and active hexamer.
Results
The ClpC M-domain represses ClpC activity
To study the function of the M-domain (MD) in ClpC activity control we first purified S. aureus ClpC/
ClpP and demonstrated functionality by determining high-proteolytic activity in presence of the
adaptor MecA (Figure 1). Next, we created a series of ClpC MD variants by mutating conserved res-
idues not involved in coiled-coil structure formation (Figure 1—figure supplement 1A). Additionally,
we replaced the entire MD (N411-K457) by a di-glycine linker, allowing MD deletion without interfer-
ing with folding of the AAA-1 domain. Proteolytic activities of MD mutants were determined using
Fluorescein-labeled casein (FITC-casein) as constitutively misfolded model substrate in absence and
presence of MecA (Figure 1A/B). ClpC wild type (WT) together with ClpP exhibited only a low pro-
teolytic activity in absence of MecA and FITC-casein degradation rates were 20-fold increased upon
adaptor addition. In contrast, most MD mutants enabled for adaptor-independent FITC-casein pro-
teolysis to varying degrees. ClpC-F436A, ClpC-R443A and ClpC-D444A showed highest activities
with degradation rates close to those determined for ClpC WT plus MecA (Figure 1A/B). Similarly,
MD deletion strongly increased ClpC activity, indicating that the single point mutants reflect a loss
of M-domain function. MecA presence still stimulated FITC-casein degradation by ClpC MD mutants
except F436A and DM, consistent with the crucial function of F436 in MecA binding (Figure 1A)
(Wang et al., 2011). To analyze whether M-domain mutants cause full activation of ClpC, we com-
pared FITC-casein degradation rates of ClpC-F436A and ClpC/MecA under saturating conditions
(Figure 1—figure supplement 1B/C). ClpC-F436A degraded FITC-casein with similar efficiencies as
ClpC/MecA at all substrate concentrations tested and reached identical vmax. ClpC-R443A and
ClpC-DM also degraded FITC-casein at saturating concentrations like MecA-activiated ClpC, under-
lining complete activation of ClpC upon M-domain mutation (Figure 1—figure supplement 1C)
Notably, we observed minor FITC-casein degradation by ClpC at higher substrate concentrations
and indicating partial ClpC activation without adapter.
FITC-casein degradation by activated ClpC M-domain mutants (F436A, DM) required ATP hydro-
lysis and was not observed in presence of ATPgS (Figure 1—figure supplement 1D). Complete deg-
radation of FITC-casein by ClpC-F436A was confirmed by SDS-PAGE (Figure 1—figure supplement
2), while ClpC WT required MecA to exhibit proteolytic activity. Here, we also noticed degradation
of MecA degradation once FITC-casein was digested, in agreement with former findings for the B.
subtilis ClpC/MecA system (Schlothauer et al., 2003; Mei et al., 2009; Turgay et al., 1998). We
infer that ClpC MD mutants exhibit high, adaptor-independent proteolytic activities, qualifying the
M-domain as a negative regulatory element.
To further investigate a repressing function of the ClpC MD we determined GFP-SsrA degrada-
tion activities of selected ClpC MD mutants exhibiting highest FITC-casein degradation activities
(F436A, R443A, DM). GFP-SsrA harbors the 11-meric SsrA tag, which is recognized by AAA+ chaper-
rones pore sites (Hinnerwisch et al., 2005; Piszczek et al., 2005; Siddiqui et al., 2004). GFP-SsrA
degradation requires application of high unfolding force in contrast to FITC-casein, which is constitu-
tively unfolded. ClpC WT/ClpP efficiently degraded GFP-SsrA in a MecA-dependent manner
(Figure 1C). Surprisingly, ClpC MD mutants did hardly exhibit autonomous degradation of GFP-SsrA
in contrast to FITC-casein. ClpC-R443A was partially stimulated upon MecA addition demonstrating
that the M-domain mutant can process GFP-SsrA in principle (Figure 1—figure supplement 3A).
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We speculated that differences in GFP-SsrA and FITC-casein binding modes might be the cause of
the different degradation activities of ClpC MD mutants. Hsp100 N-domains contribute to casein
binding (Beinker et al., 2002; Rosenzweig et al., 2015) while their position on top of the AAA-1
ring and central pore site could impede GFP-SsrA binding. We therefore determined GFP-SsrA deg-
radation activities of N-domain deleted DN-ClpC and respective MD mutants (Figure 1D). GFP-SsrA
remained stable in presence of DN-ClpC/ClpP, however, the substrate was rapidly degraded by DN-
ClpC-F436A, DN-ClpC-R443A and DN-ClpC-DM (+ClpP) and degradation rates were identical to
those determined for ClpC WT/ClpP with MecA (Figure 1E). We did not test for GFP-SsrA
0
.0
0 0
.0
3
0
.6
1
0
.1
2
0
.1
2 0
.1
9
0
.2
2
0
.0
7
0
.2
0
0
.4
5
0
.1
3
0
.4
0
0
.3
4
0
.0
1
0
.2
5
0.0
0.2
0.4
0.6
0.8
P
W
T
W
T 
+ 
M
ec
A
K
41
4A
E
41
5A
E
41
7A
E
42
6A
K
42
7A
E
43
5A
F4
36
A
E
43
7A
R
44
3A
D
44
4A
E
45
5A 'M 0 20 40 60 80
0.5
1.5
2.5
3.5
4.5
5.5
re
la
ti
v
e
 F
IT
C
 c
a
s
e
in
 f
lu
o
re
s
c
e
n
c
e
WT + MecA
F436A
R443A
'M
WT
ClpP
time / min
A
Figure 1
0 5 10 15 20 25 30 35
0
25
50
75
100
125
0.
1
11
.0
0.
2
0.
20.
4
2.
9
0.
4
0.
5
0.
1
11
.8
11
.3
10
.7
0
2
4
6
8
10
12
14
G
F
P
-S
s
rA
 f
lu
o
re
s
c
e
n
c
e
 (
%
)
C D
0
25
50
75
100
125
G
F
P
-S
s
rA
 f
lu
o
re
s
c
e
n
c
e
 (
%
)
E
time / min
0 5 10 15 20 25 30 35
time / min
G
F
P
-S
s
rA
 d
e
g
ra
d
a
ti
o
n
 r
a
te
(%
) 
/ 
m
in
W
T
W
T
F
4
3
6
A
F
4
3
6
A
R
4
4
3
A
R
4
4
3
A'M 'M WT
F
4
3
6
A
R
4
4
3
A 'M
WT
F436A
R443A
'M
WT + MecA
'N WT
'N F436A
'N R443A
'N 'M
B
- MecA + MecA 'N
0.9
0.7
0.5
0.3
0.1
0
.4
1
0
.3
3
0
.4
8 0
.5
6
0
.2
2
0
.5
5
0
.3
9 0
.4
3
0
.3
4
0
.6
5
0
.5
1
0
.1
9
0
.0
0
- MecA
+ MecA
F
IT
C
 c
a
s
e
in
 d
e
g
ra
d
a
ti
o
n
 r
a
te
(r
e
la
ti
v
e
 'F
5
2
0
 n
m
 /
 m
in
)
Figure 1. ClpC MD mutants exhibit adaptor-independent proteolytic activity. (A/B) FITC-casein degradation was monitored in the presence of ClpP (P)
only, or in presence of ClpC wild type and indicated MD mutants with or without MecA. Degradation rates were determined from the initial linear
increase of FITC fluorescence. Initial FITC-casein fluorescence was set as one and relative changes in fluorescence were recorded. (C–E) GFP-SsrA
degradation was monitored in the presence of ClpP and indicated ClpC variants. Deletion of the N-terminal domain (DN) unleashes high proteolyic
activity of MD mutants. GFP-SsrA degradation rates were determined from the initial linear decrease of GFP-SsrA fluorescence.
DOI: https://doi.org/10.7554/eLife.30120.003
The following figure supplements are available for figure 1:
Figure supplement 1. Analysis of ClpC MD mutants.
DOI: https://doi.org/10.7554/eLife.30120.004
Figure supplement 2. Degradation of FITC-casein by the ClpC-F436A MD mutant.
DOI: https://doi.org/10.7554/eLife.30120.005
Figure supplement 3. Degradation of GFP-SsrA by ClpC MD mutants.
DOI: https://doi.org/10.7554/eLife.30120.006
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degradation by DN-ClpC/ClpP in presence of MecA, as the N-domain is essential for MecA binding
(Wang et al., 2011; Kirstein et al., 2006; Persuh et al., 1999).
By determining GFP-SsrA degradation rates under saturating conditions we confirmed that DN-
ClpC-F436A is as active as MecA-activated ClpC and degraded the substrate with similar or even
faster kinetics (Figure 1—figure supplement 3B). Similar results were obtained for DN-ClpC-R443A
and DN-ClpC-DM when determining degradation rates in presence of 30-fold GFP-SsrA excess (Fig-
ure 1—figure supplement 3C).
GFP-SsrA degradation by activated DN-ClpC M-domain mutants relied on ATP hydrolysis and
remained specific as the substrate variant GFP-SsrA-DD was not degraded (Figure 1—figure sup-
plement 3D). Here, the two C-terminal alanine residues of the SsrA tag are replaced by aspartate
residues, obstructing binding to the AAA+ chaperone pore site (Flynn et al., 2001). This documents
that MD mutations boost ClpC unfolding activity in absence of adaptor without altering general sub-
strate specificity.
ClpC M-domain mutants exhibit increased basal ATPase activities
B. subtilis ClpC activation by adaptors involves strong stimulation of ClpC ATPase activity
(Turgay et al., 1997; Mei et al., 2009; Persuh et al., 1999), which we confirm here for S. aureus
ClpC and MecA (Figure 2A). ClpC WT exhibits a very low basal ATPase activity (0.4 ATP/min/mono-
mer), rationalizing its poor standalone degradation activity. Notably, all activated MD mutants
(F436A, R443A, DM) exhibited strongly increased basal ATPase activities (3.3–5.4 ATP/min/mono-
mer) that were further increased by substrate casein (1.64–2.47-fold stimulation) in contrast to ClpC
WT (Figure 2A/B). In presence of MecA, a minor stimulation (1,21-fold) of ClpC ATPase activity by
casein was determined. In this setup lower MecA concentrations (0.2 mM) were used to minimize
competition between casein and MecA as both can act as ClpC substrate. Casein-stimulated ClpC
MD mutants reached 33% of total ATPase activity determined for MecA-activated ClpC WT.
N-domain deletion also increased basal ATPase activity of DN-ClpC. Combining DN-ClpC with
M-domain mutants had an additive stimulatory effect on ATPase activities, suggesting that the
underlying mechanisms are distinct from one another (Figure 2A). We infer increased basal ATPase
activities of ClpC MD mutants (in context of fullength ClpC and DN-ClpC) can explain adaptor-
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Figure 2. ClpC MD mutants exhibit increased basal ATPase activity that can be stimulated by substrate. (A) ATPase activities of ClpC wild type (WT)
and indicated deletion variants (DN, DM) and MD mutants were determined in absence and presence of MecA. (B) ATPase activities of ClpC wild type
(WT, ±MecA) and indicated MD mutants were determined in absence and presence of substrate casein. ATPase activities determined without casein
were set as one and the relative increase of ATP hydrolysis in presence of casein was determined (stimulation factor).
DOI: https://doi.org/10.7554/eLife.30120.007
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independent substrate degradation. However, ATPase activation alone is not sufficient to explain
ClpC activation as DN-ClpC did not allow degradation of GFP-SsrA despite having increased basal
ATPase activity. This indicates specific consequences of MD mutations on ClpC conformation and
activity.
Head-to-head interactions of M-domains mediate formation of an
inactive ClpC resting state
To understand the structural basis underlying the control of ClpC activity by the MD, we determined
the cryo-EM structures of S. aureus ClpC with and without its activator MecA in the presence of
ATPgS. The structure of ClpC on its own was solved at 8.4 A˚ resolution using ~90.000 collected par-
ticles (Figure 3—figure supplement 1). Surprisingly, raw images and subsequent 2D classification
revealed immediately that ClpC assumes a conformation different from the canonical hexameric
arrangement of AAA+ proteins (Figure 3—figure supplement 1A/B). Attempts of 3D classification
and refinement using the existing ClpC-MecA structures (Wang et al., 2011; Liu et al., 2013) failed
to give a refined map, indicating that on its own, ClpC assumes a substantially different conforma-
tion. Indeed, reconstructions revealed that ClpC without MecA assembles into an oligomeric assem-
bly made of two open spirals that interact via head-to-head contacts mainly mediated by the MDs
(Figure 3A/B, Figure 3—figure supplement 1). Continuous spiraling of AAA+ proteins is often
observed in X-ray structures (Carroni et al., 2014; Heuck et al., 2016; Lee et al., 2003; Guo et al.,
2002) and ClpC half spirals are similar to these crystal packings. More specifically, ClpC half spirals
have inter-subunit interfaces similar to the crystal structure of Hsp104 (PDB code: 5d4w)
(Heuck et al., 2016) and the EM map of Hsp104 in complex with ADP (PDB code: 5vy8)
(Gates et al., 2017). ClpC did not form a half spiral but a double spiral that is open on one side
(Figure 3A/B, Figure 3—figure supplement 1A/B, Figure 3—video 1) resulting in a cradle-like mol-
ecule with the peripheral subunits more mobile than the core ones, as shown by lower local resolu-
tion (Figure 3—figure supplement 2A). Additionally, high-threshold noise on the open part of the
spiral indicates higher dynamics of this region, suggesting exchange of subunits. Accordingly, for
peripheral ClpC subunits there is not sufficient density to account for all ClpC domains (Figure 3—
figure supplement 2B). Local focused 3D classification of these peripheral regions failed to give
well-defined density further suggesting high-mobility.
The overall subdomain organization within the ClpC protomer is similar to that of the ClpC-MecA
crystal structures, however domain positions and interactions are different. The AAA+ domains are
staggered with a rise of ~20 A˚ per subunit (Figure 3B). N-domains domains are packed between
MDs and are displaced so that they lie on top of the adjacent small AAA1 subdomain (Figure 3B/C).
The MDs coiled-coils constitute the backbone of the spiral and mediate the spiral head-to-head con-
tacts, which involve residues F436, R443 and D444 providing a structural rationale for the activated
states of respective MD mutants (Figure 3D). The MD-MD head-to-head interaction stops the forma-
tion of virtually infinite spirals as in the Hsp104 crystal arrangements allowing the formation of a
compact, repressed ClpC reservoir.
We envision the helical ClpC assembly as a dynamic inactive resting state, which will interfere
with substrate binding, association of the ClpP peptidase and interaction with adaptor proteins.
The S. aureus ClpC-MecA cryo-EM map was reconstructed at 11 A˚ resolution with ~26,000 par-
ticles, (Figure 3—figure supplement 3A–D) and shows the classical hexameric assembly previously
described (Wang et al., 2011; Liu et al., 2013), with MecA interacting with both the MD and the
N-domain of ClpC (Figure 3E). Additional extra density caps the hexamer and accounts for the
N-terminal domain of MecA, whose structure is unknown. From the resting to the MecA-bound state
the N-domains undergo a 45˚ rotation that repositions the MecA-binding loop region from being
blocked by the MD of the neighbouring subunit to be available and engaged in MecA binding (Fig-
ure 3—figure supplement 3E/F). Additionally, binding of MecA to MDs breaks head-to-head MD
contacts and is therefore expected to prevent formation of the ClpC resting state.
Taken together, our structures of ClpC alone or in complex with MecA show a dramatic reorgani-
zation from a helical resting state to a planar canonical AAA+ hexamer, explaining ClpC activation
by the adaptor MecA. Intermolecular head-to-head contacts of MDs form the backbone of the ClpC
resting state, qualifying the MD as crucial negative regulatory element consistent with MD mutant
characterization.
Carroni et al. eLife 2017;6:e30120. DOI: https://doi.org/10.7554/eLife.30120 6 of 24
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Figure 3. Cryo-EM structures of S. aureus ClpC-ATPgS with and without MecA. (A) Overview of the oligomeric ClpC resting state 3D map coloured by
subunits. (B) ClpC density map coloured by domains. Head-to-head interactions between MDs (green) of each helical assembly are key contacts
stabilizing the ClpC resting state. ClpC domain organization is given, including an N-terminal domain (NT, yellow), AAA-1 large subdomain (L-AAA1,
red), coiled-coil M-domain (MD, green), AAA-1 small subdomain (S, orange), AAA-2 large subdomain (L-AAA2, blue) and AAA-2 small subdomain (S,
cyan). (C) Details of fitting for each ClpC subdomain. The small inset shows the positions relative to the whole molecule. (D) Zoomed view into MD-MD
contacts highlighting conserved MD residues involved in interactions. The small inset shows the positions relative to the whole molecule. (E) Structure
of the ClpC-MecA complex. Fitted atomic model coloured by ClpC domains as in b and MecA C-terminal domains (purple). Density for MecA
N-terminal domains is indicated.
DOI: https://doi.org/10.7554/eLife.30120.008
The following video and figure supplements are available for figure 3:
Figure supplement 1. Cryo-EM structure of S.
DOI: https://doi.org/10.7554/eLife.30120.009
Figure supplement 2. (A) Local-resolution map of ClpC-ATPgS complex.
DOI: https://doi.org/10.7554/eLife.30120.010
Figure supplement 3. Cryo-EM structure of S. aureus ClpC-MecA-ATPgS complex.
DOI: https://doi.org/10.7554/eLife.30120.011
Figure 3—video 1. Structural organization of the ClpC resting state.
DOI: https://doi.org/10.7554/eLife.30120.012
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MecA abrogates head-to-head M-domain interactions
To demonstrate direct head-to-head contacts of ClpC MDs we introduced cysteine residues at the
tip of the MD (E435C, E437C) to probe for site-specific disulfide crosslinking. These mutations were
introduced into ClpC-C311T to avoid interference of the endogenous Cys311 residue. ClpC-C311T/
E435C and ClpC-C311T/E437C were active in MecA-dependent protein degradation under reducing
conditions (Figure 4—figure supplement 1A). Formation of crosslink products under oxidizing con-
ditions that were fully reverted by addition of reducing agent was observed for ClpC-C311T/E437C
but not for ClpC-C311T/E435C and the ClpC-C311T control (Figure 4—figure supplement 1B).
This documents specificity of disulfide crosslinking and agrees well with the ClpC resting state
model, showing E437 residues of two interacting M-domains are facing one another while E435 resi-
dues are oriented in opposite directions (Figure 4—figure supplement 1B). E437C disulfide cross-
linking was most efficient in absence of nucleotide or presence of ADP and ATP, and less efficient in
presence of ATPgS (Figure 4—figure supplement 1C). Importantly, ClpC-E437C crosslinking in
presence of MecA was strongly reduced (Figure 4A), consistent with MecA binding to MDs prevent-
ing head-to-head MD interactions. Similarly, crosslinking efficiency was reduced for ClpC-F436A/
E437C, indicating a crucial contribution of F436 to intermolecular MD contacts (Figure 4B), consis-
tent with the ClpC WT cryo-EM structure.
Obstructing head-to-head M-domain contacts allows for ClpC hexamer
formation
To provide biochemical support for the formation of a large, inactive ClpC resting state we
employed chemical crosslinking and size exclusion chromatography. We used the ATPase-deficient
ClpC-E280A/E618A variant (referred to as ClpC-DWB), harboring mutated Walker B motifs in both
AAA+ domains allowing for ATP binding but not hydrolysis, facilitating analysis of adaptor or sub-
strate impact on ClpC assembly. We first determined sizes of ClpC assemblies by glutaraldehyde
crosslinking (Figure 5A). ClpC-DWB was crosslinked to very large assemblies that were just entering
the separating gel in SDS-PAGE in absence and presence of ATP (Figure 5A). Addition of MecA
allowed for formation of a smaller high molecular weight complex similar in size to crosslinked ClpB
hexamers that were used as reference (Figure 5A). Presence of MecA in the crosslinked ClpC-DWB
complexes was confirmed by western-blot analysis (Figure 5—figure supplement 1). We still
observed crosslinking of ClpC to high molecular weight products in presence of MecA. These might
stem from transient interactions between ClpC/MecA hexamers via MecA-MecA interactions as
MecA can target itself for degradation. ClpC-F436A-DWB stayed monomeric in absence of nucleo-
tide, indicating that large assemblies observed for ClpC-DWB rely entirely on MD contacts
(Figure 5A). ClpC-F436A-DWB crosslinking in presence of ATP caused formation of defined ClpC-
F436A-DWB complexes that were similar in size to crosslinked ClpB hexamers. These findings con-
firm the predicted critical contribution of the MD to formation of a large resting state and the role of
MecA in converting this assembly into a functional hexamer.
Since N-domains are packed between MDs in the resting state and lie on top of the adjacent
AAA-1 domain we analyzed oligomerization of DN-ClpC and DN-ClpC-F436A by crosslinking
(Figure 5B). In absence of nucleotide DN-ClpC stayed monomeric, suggesting that N-domain con-
tacts to AAA-1 contribute to assembly formation. However, in presence of ATPgS, DN-ClpC was still
crosslinked to high molecular weight complexes larger than ClpB hexamers indicating N-domains
are not essential for resting state formation whereas nucleotide binding to AAA domains is crucial
(Figure 5B). DN-ClpC-F436A (+ATPgS) was predominantly crosslinked to hexamers, demonstrating
the unique and dominant role of MDs in controlling resting state formation.
We next analyzed sizes of ClpC complexes by size exclusion chromatography (Figure 5C, Fig-
ure 5—figure supplement 2A). In absence of ATP ClpC-DWB showed a broad elution profile, sug-
gesting formation of variable assemblies ranging from monomers to hexamers. ATP addition caused
formation of larger ClpC assemblies that eluted prior to ClpB hexamers and a 670 kDa standard pro-
tein, suggesting formation of ClpC complexes larger than hexamers (Figure 5C, Figure 5—figure
supplement 2A). This was confirmed by static light scattering (SLS) measurements, revealing a
molecular mass of » 956 kDa corresponding to a decameric complex, consistent with cryoEM analy-
sis (Figure 5—figure supplement 2B). Presence of MecA sharpened the ClpC elution profile and
shifted ClpC-DWB fractions to later elution volumes right after the 670 kDa standard protein and
Carroni et al. eLife 2017;6:e30120. DOI: https://doi.org/10.7554/eLife.30120 8 of 24
Research article Biochemistry
70
100
130
180
C311T
E437C
C311T
E437C
MecA
ATPγS
MecA
ATP
-
+
+
+
-
+
+
+
A
E437C
B
70
100
130
180
C311T
E437C
C311T
E437C
F436A
β-Me
min
-
0
-
2
+
2
-
0
-
2
+
2
- cys-cys dimer
- cys-cys dimer
- monomer
- monomer
Figure 4. Disulfide crosslinking demonstrates MecA-sensitive head-to-head MD contacts. (A) Disulfide crosslinking
of ClpC-C311T/E437C under oxidizing conditions was performed in presence of ATPgS or ATP without or with
MecA and analyzed by subsequent non-reducing SDS-PAGE. A model of head-to-head interacting MDs is given
and the position of E437 is indicated. (b) Disulfide crosslinking of ClpC-C311T/E437C and ClpC-C311T/F436A/
Figure 4 continued on next page
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now overlapping with ClpB hexamers (Figure 5C, Figure 5—figure supplement 2A). Quantification
of co-eluting MecA suggests the formation of a 1:1 ClpC:MecA complex, consistent with the binding
stoichiometry determined for B. subtilis ClpC/MecA complexes and mass determination by SLS (767
kDa) (Figure 5—figure supplement 2B) (Wang et al., 2011; Kirstein et al., 2006). This indicates
that MecA binding shifts ClpC from a large, non-hexameric assembly to a ClpC6/MecA6 complex.
We next analyzed the elution profile of ClpC-DWB-F436A. In absence of ATP the MD mutant eluted
as defined species right at the elution volume of a 158 kDa standard protein suggesting formation
of monomers/dimers (Figure 5C). This indicates that the formation of larger assemblies noticed for
ClpC WT (- ATP) depends on the M-domain, consistent with results from glutaraldehyde crosslinking
(Figure 5A) Unexpectedly, ClpC-DWB-F436A showed a broad elution profile upon ATP addition.
While the ClpC-DWB-F436A peak fraction eluted right after the 670 kDa standard, larger assemblies
at earlier elution volumes were also present. We speculated that activated ClpC MD mutants might
be capable of recognizing themselves as substrate resulting in formation of larger complexes and
explaining the elution profile. Indeed, we observed autodegradation of ClpC-F436A, ClpC-R443A
and ClpC-DM but not ClpC WT in presence of ClpP (Figure 5—figure supplement 3). To prevent
self-recognition of ClpC-DWB-F436A we repeated the size exclusion analysis in presence of sub-
strate casein excess (Figure 5C). Presence of casein sharpened the ClpC-DWB-F436A elution profile
that was comparable to ClpC-DWB/MecA complexes and distinct from ClpC-DWB, suggesting hex-
amer formation, which was confirmed by mass determination by SLS (587 kDa) (Figure 5C, Fig-
ure 5—figure supplement 2B). In contrast, casein addition did not cause formation of smaller ClpC-
DWB complexes (Figure 5—figure supplement 2B). To further prove ClpC-F436A hexamer forma-
tion, a small cryo-EM dataset of ClpC-F436A with casein and ATPgS was collected and analyzed via
2D classification. Classes indicate that the ClpC-F436A assembles in an hexamer similar to ClpC WT
with MecA (Figure 5D).
Together our findings demonstrate that ClpC-DWB forms large, non-hexameric assemblies in a
MD dependent manner, supporting the derived ClpC WT cryo-EM structure. This large ClpC-DWB
assembly should neither allow for efficient substrate binding nor association with the ClpP pepti-
dase. This prediction was confirmed by size exclusion chromatography showing poor interaction
with ClpP and negligible binding to substrate FITC-casein (Figure 5E, Figure 5—figure supplement
2C). In contrast, efficient binding to FITC-casein and ClpP was observed upon addition of MecA and
for ClpC-DWB-F436A (- MecA) (Figure 5E, Figure 5—figure supplement 2C). These findings were
further confirmed by monitoring FITC-casein binding by anisotropy measurements (Figure 5—figure
supplement 2D/E).
M-domain activity control of ClpC is crucial for cellular viability
ClpC MD mutants allow for adaptor-independent and thus constitutive and uncontrolled ClpC activ-
ity. We wondered whether this loss of ClpC activity control has physiological consequences and co-
expressed S. aureus ClpC WT, DN-ClpC and respective F436A mutants from an IPTG-regulated pro-
moter together with S. aureus ClpP in E. coli cells. This strategy allowed us to only monitor potential
toxic effects of ClpC M-domain mutants without interference by loss of endogenous functions of
ClpC/MecA in S. aureus cells. Levels of ClpC variants were similar after 1 hr of IPTG-induced protein
production (Figure 6—figure supplement 1A). In case of ClpC-F436A we noticed accumulation of a
degradation product upon ClpP coexpression, as also observed in vitro (Figure 5—figure supple-
ment 3), suggesting autoprocessing. We observed strong toxicity upon expression of DN-ClpC-
F436A at all temperatures tested while ClpC-F436A expression became lethal at 37˚C and 40˚C
(Figure 6A). Toxicity of ClpC MD mutants was much higher as compared to ClpC-WT and DN-ClpC,
Figure 4 continued
E437C was performed in presence of ATPgS under oxidizing (+Cu(Phe3)) and reducing (+ b-mercaptoethanol)
conditions and analyzed by subsequent non-reducing SDS-PAGE.
DOI: https://doi.org/10.7554/eLife.30120.013
The following figure supplement is available for figure 4:
Figure supplement 1. Disulfide crosslinking of head-to-head interacting MDs.
DOI: https://doi.org/10.7554/eLife.30120.014
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Figure 5. ClpC forms a large, inactive resting state that is sensitive to MecA and MD mutation. (A) Glutaraldehyde crosslinking of ClpC-E280A/E618A
(ClpC-DWB) and a respective MD mutant variant (F436A) was performed in absence and presence of ATP without and with MecA as indicated.
Crosslinking of E. coli ClpB in presence of ATPgS served as reference defining crosslinked hexameric assemblies. Crosslink products were analyzed by
SDS-PAGE. (B) Glutaraldehyde crosslinking of DN-ClpC and DN-ClpC-F436A was performed in absence and presence of ATPgS as indicated.
Figure 5 continued on next page
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suggesting an essential cellular need for ClpC repression by MDs. Furthermore, toxicity of ClpC MD
mutants was dependent on coexpression of S. aureus ClpP, suggesting that uncontrolled protein
degradation caused by constitutively activation results in cell death (Figure 6—figure supplement
1B). We also noticed toxic effects when co-expressing MecA, ClpC and ClpP in E. coli cells (Fig-
ure 6—figure supplement 1C), substantiating that ClpC-F436A toxicity is caused by its constitutive
activation. Toxicity of MecA/ClpC/ClpP was somewhat lower as compared to e.g. ClpC-F436A, but
eventually also restricted by strong MecA degradation (Figure 6—figure supplement 1D).
To further explore a cellular need for ClpC activity control we determined the physiological con-
sequences of the same ClpC MD mutation in B. subtilis cells harboring a complete set of ClpC
adapter proteins. Here, we deleted the chromosomal copy of the clpC gene (clpC::tet) and re-inte-
grated either clpC wt or clpC-F436A at the amyE-locus under IPTG control. Expression of clpC-
F436A but not clpC wt in presence of 100 mM IPTG was highly toxic at all temperatures (30–50˚C)
(Figure 6B). Levels of ClpC-wt and ClpC-F436A produced after IPTG addition in cells cultured in liq-
uid medium were comparable, excluding differences in protein levels as reason for toxicity (Fig-
ure 6—figure supplement 1E). Importantly, growth of clpC::tet cells was not impaired,
demonstrating that toxicity of ClpC-F436A reflects a gain-of-function phenotype and is not caused
by loss of adaptor interaction (Figure 6B). Together these findings demonstrate an essential role of
MD mediated activity control for cellular viability.
The Hsp100 family members ClpE and ClpL harbor a coiled-coil MD that is similar in size to the
ClpC MD and also displays some sequence homology. Notably, F436 and R443, identified here as
key MD residues in ClpC activity control, are largely conserved in ClpE and ClpL M-domains
(Figure 6C). This suggests that the role of M-domains as crucial negative regulators of Hsp100 activ-
ity is conserved in other family members. To test for a conserved regulatory function we generated
the B. subtilis ClpE-Y344A MD mutant corresponding to ClpC-F436A. clpE wt and clpE-Y344A cop-
ies were integrated at the amyE-locus in B. subtilis wild type cells under control of an IPTG-regulat-
able promoter. B. subtilis cells do hardly express endogenous clpE at non-stress conditions
(Gerth et al., 2004; Miethke et al., 2006) thereby allowing mutant analysis without interference of
ClpE WT copies. Expression of clpE-Y344A but not clpE wt in presence of 100 mM IPTG was highly
toxic to B. subtilis cells at all temperatures tested (30–50˚C) (Figure 6D). ClpE WT and ClpE-Y344A
were produced to similar levels underscoring that toxicity is caused by deregulation of the ClpE MD
mutant (Figure 6—figure supplement 1F). This suggests that ClpE MDs are also essential to down-
regulate ClpE activity preventing cellular toxicity.
Discussion
In the presented work we established a new mechanism of activity control of ClpC, a central AAA+
chaperone widely distributed among Gram-positive bacteria. We show that coiled-coil MDs control
ClpC activity in a unique manner by sequestering ClpC molecules in an inactive resting state.
Figure 5 continued
Crosslinking of E. coli ClpB in presence of ATPgS served as reference defining crosslinked hexameric assemblies. Crosslink products were analyzed by
SDS-PAGE. (C) Oligomeric states of ClpC-DWB and ClpC-F436A-DWB were determined in absence and presence of ATP. Addition of MecA and casein
is indicated. Elution fractions were analyzed by SDS-PAGE and quantified. Positions of peak fractions of a protein standard and ClpB-E279A/E678A
hexamers (+ATP) are indicated. (D) Micrograph of ClpC-F436A sample in presence of casein (top). Examples of single particles are circled. 2D class
averages of ClpC-F436A (bottom). Scale bar is 10 nm. (E) Binding of FITC-casein to ClpC-DWB and ClpC-F436A-DWB was analyzed in presence of ATP
by size exclusion chromatography. FITC-casein fluorescence of elution fractions was quantified. Positions of peak fractions of a protein standard and
ClpB-E279A/E678A hexamers (+ATP) are indicated.
DOI: https://doi.org/10.7554/eLife.30120.015
The following figure supplements are available for figure 5:
Figure supplement 1. MecA is crosslinked to a high molecular weight complex upon ClpC binding.
DOI: https://doi.org/10.7554/eLife.30120.016
Figure supplement 2. ClpC-ATP forms an inactive large resting state.
DOI: https://doi.org/10.7554/eLife.30120.017
Figure supplement 3. Autodegradation of ClpC MD mutants.
DOI: https://doi.org/10.7554/eLife.30120.018
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Figure 6. Loss of ClpC activity control is toxic in vivo. (A) E. coli cells constitutively expressing S. aureus clpP and harboring the indicated plasmid-
encoded clpC alleles under control of an IPTG-regulatable promoter were grown overnight at 30˚C and adjusted to OD600 of 1. Serial dilutions (10 2 –
10 6) were spotted on LB plates containing the indicated IPTG concentrations and incubated at 30˚C, 37˚C or 40˚C for 24 hr. (B) B. subtilis DclpC
control cells and DclpC mutant cells harboring a clpC wild type (WT) or MD mutant (F436A) copy integrated at the amyE-locus under control of an
Figure 6 continued on next page
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Our findings extend the role of coiled-coil MDs as regulatory devices controlling AAA+ protein
activity. MDs of the ClpB/Hsp104 disaggregases function as molecular toggles, which are crucial for
AAA+ protein repression in the ground state and activation by an Hsp70 partner chaperone
(Oguchi et al., 2012; Heuck et al., 2016; Rosenzweig et al., 2013; Lee et al., 2013; Seyffer et al.,
2012) (Figure 7). Repression by ClpB/Hsp104 MDs relies on formation of a repressing belt around a
canonical AAA+ ring by interacting with AAA-1 domains and neighboring MDs. Intermolecular
head-to-tail contacts between long MDs (~120 residues forming two wings) are crucial to keep MDs
in a horizontal, repressing conformation (Carroni et al., 2014) (Figure 7). Hsp70 binding to the tip
of one wing breaks MD interactions and leads to ClpB activation.
ClpC MDs cannot function in the same manner due to their reduced size (~50 residues forming a
single wing), which is too short to span the distance between neighboring subunits in a hexameric
assembly. Instead, ClpC MDs form intermolecular head-to-head contacts allowing docking of two
layers of ClpC molecules arranged in a helical conformation (Figure 7). The formation of this struc-
ture also involves ATP binding to AAA domains. We define this large ClpC assembly as inactive rest-
ing state, as it strongly restricts binding of substrates, ClpP and adaptor proteins and does not allow
for efficient ATP hydrolysis.
Thereby ClpC MDs function as molecular switches, similar to ClpB/Hsp104 MDs, ensuring repres-
sion in the ground state and allowing for activation in presence of substrate recruiting adaptors (Fig-
ure 7). This dual activity is best illustrated for MD residue F436 located at the tip of the coiled-coil
structure. F436 is essential for both, intermolecular MD interaction and MecA binding (Figure 7).
The N-terminal domain, though not being essential for resting state formation, appears to play an
additional role in this switch of conformations, by going from a more hidden position in between
MDs in the resting state to a more exposed one, available to MecA or other adaptors.
The interaction surface of MDs is limited (50 A˚2) which has implications on the stability of the rest-
ing state complex. We speculate that multiple MD contacts provide sufficient stickiness to stabilize a
resting state core, while providing dynamics to peripheral subunits, in agreement with our structural
and biochemical analysis. As MecA-binding sites in N- and M-domains are not accessible in the rest-
ing state, we suggest that ClpC subunit dissociation is prerequisite for MecA binding. Additionally,
MecA might bind to peripheral subunits of the ClpC storage state causing their displacement. We,
however, do not exclude a scenario in which dissociation of the complete ClpC double-spiral takes
place, allowing for more direct transition into hexamers upon MecA-binding to a single ClpC spiral.
Our newly derived model of S. aureus ClpC activity control differs from a former one, showing
that B. subtilis ClpC is monomeric and requires MecA for hexamer formation (Kirstein et al., 2006).
Sequestering inactive ClpC subunits in a resting state structure might provide better protection
against non-specific interactions with other cellular components or degradation by proteases as
compared to freely accessible monomers. We realize that former ClpC analysis was performed in
presence of high salt concentrations (300 mM NaCl), which likely interfere with MD head-to-head
contacts involving charged residues (R443, D444). A regulatory model involving only monomer-hex-
amer transitions cannot explain activation and severe cellular toxicity of ClpC MD mutants shown
here in E. coli and B. subtilis cells. However, we suggest that the oligomerization dependence of
ClpC on MecA at high salt concentrations might represent a fail-safe system ensuring adaptor-
dependent ClpC activation under conditions that do not allow for resting state formation (e.g. salt
stress).
Figure 6 continued
IPTG-regulatable promoter were grown at 30˚C to OD600 = 1. Serial dilutions (10 2 – 10 6) were spotted on LB plates without or with 100 mM IPTG and
incubated at 30˚C, 37˚C or 50˚C for 24 hr. (C) Sequence alignment of MDs from ClpC, ClpE and ClpL proteins. A highly conserved aromatic residue
located at the tip of the coiled-coil structure is highlighted. (D) B. subtilis cells harboring an extra clpE wild type (WT) or MD mutant (Y344A) copy
integrated at the amyE-locus under control of an IPTG-regulatable promoter were grown at 30˚C to OD600 = 1. Serial dilutions (10 2 – 10 6) were
spotted on LB plates without or with 100 mM IPTG and incubated at 30˚C, 37˚C or 50˚C for 24 hr.
DOI: https://doi.org/10.7554/eLife.30120.019
The following figure supplement is available for figure 6:
Figure supplement 1. Expression of toxic ClpC MD mutants.
DOI: https://doi.org/10.7554/eLife.30120.020
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Once formed the hexameric ClpC6/MecA6 complex is stable and does not dissociate spontane-
ously, raising the question how ClpC activation is turned off. Adaptor proteins are targeting them-
selves for degradation by ClpC/ClpP if substrates are no longer available (Mei et al., 2009;
Turgay et al., 1998; Kirstein et al., 2007). This mechanism couples substrate availability with ClpC
activation and ensures fast ClpC inactivation in absence of substrate by causing dissociation of ClpC
hexamers into monomers that are subsequently sequestered in the resting state. Notably, other
chaperone machineries including the Hsp70 member BIP (Preissler et al., 2015) and the AAA+ pro-
tein Rca (Mueller-Cajar et al., 2011) also form large, inactive resting states that are converted into
active species depending on substrate availability. Sequestration of chaperones therefore seems a
more widespread activity to tune their activities according to the physiological need.
MecA
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M-M-domain
interaction
head-to-head
M-M-domain
interaction
ClpB ClpC
DnaK
resting state
activated state
oligomer
monomer
adaptor
interaction
Figure 7. Regulatory coiled-coil MDs repress AAA+ protein activities by different mechanisms. ClpB is kept in a
low activity resting state by long MDs forming a repressive belt around the hexameric AAA ring. MDs are kept in
place by head-to-tail interactions between adjacent coiled-coils. In contrast, the ClpC resting state is formed by
head-to-head MD contacts, allowing for assembly of two open ClpC spirals. Adaptor proteins of ClpB (DnaK) and
ClpC (MecA) break MD contacts by binding to MD sites crucial for MD interactions. This results in AAA+ protein
activation by releasing MD repression on ATPase activity (ClpB) or allowing for formation of active hexamers
(ClpC).
DOI: https://doi.org/10.7554/eLife.30120.021
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Constitutively activated ClpC MD mutants exert strong toxicity in E. coli and B. subtilis cells, dem-
onstrating an essential physiological need to tightly control ClpC function. In contrast, no ClpC toxic-
ity is observed in B. subtilis cells expressing ClpC wild type, which unlike ClpC MD mutants can
interact with the complete set of its adapter proteins. This suggests that adapters confer a higher
degree of substrate specificity to ClpC as compared to activated ClpC MD mutants. We assume that
mistargeted protein degradation by deregulated ClpC MD mutants of e.g. newly synthesized pro-
teins or secretory proteins, which did not yet reach their native structures or cellular compartment,
leads to cell death.
Homologous MDs are present in the AAA+ protein family members ClpE and ClpL and key resi-
dues driving formation of the ClpC resting state are evolutionary conserved. We show that mutating
a key regulatory MD residue of ClpE also causes cellular toxicity, strongly suggesting that the repres-
sing mode of MDs established here for ClpC is also operational in ClpE and ClpL and thus is a more
general mechanism for controlling bacterial AAA+ chaperone systems.
Severe toxicity of ClpC and ClpE MD mutants qualifies these AAA+ chaperones as targets for
antimicrobials. In fact, the deregulation of bacterial proteases represents a novel antibacterial strat-
egy (Malik and Bro¨tz-Oesterhelt, 2017; Culp and Wright, 2017). Notably, the M. tuberculosis
ClpC N-terminal domain was recently identified as target of cyclic peptides with antibacterial activi-
ties (Schmitt et al., 2011; Gao et al., 2015; Gavrish et al., 2014). Although the mode of these
drugs and their effects on ClpC function are not understood it is likely that they interfere with ClpC
activity control. Our findings presented here open a new route for toxic ClpC deregulation by identi-
fying MDs as crucial regulatory elements and thus drug targets and offering a promising approach
to attack multi-drug resistant bacteria.
Materials and methods
Strains, plasmids and proteins
E. coli strains used were derivatives of MC4100, XL1-blue or DH5a. ClpC, MecA, ClpP were ampli-
fied by PCR, inserted into pDS56 and verified by sequencing. Mutant derivatives of ClpC were gen-
erated by PCR mutagenesis and standard cloning techniques in pDS56 and were verified by
sequencing. Transformation into B. subtilis 168 was performed by standard methods
(Anagnostopoulos and Spizizen, 1961). AmyE insertion in B. subtilis was checked by plating on
agar containing 0.4% starch (w/v) additionally to appropriate antibiotics, screening for successful
loss of a-amylase by staining starch with Lugol’s iodine.
ClpC and variants, MecA and ClpP were purified after overproduction from E. coliDclpB::kan cells.
GFP-SsrA was purified after overproduction from E. coli DclpX DclpP cells. All proteins were purified
using Ni-IDA (Macherey-Nagel) and size exclusion chromatography (Superdex S200, GE Healthcare)
following standard protocols. Pyruvate kinase of rabbit muscle, casein and FITC-casein were pur-
chased from Sigma. Protein concentrations were determined with the Bio-Rad Bradford assay.
Biochemical assays
Size exclusion chromatography and multi-angle light scattering
Complex formation of ClpC (10 mM) was monitored by size exclusion chromatography (SEC, Super-
ose 6 10/300 GL, GE Healthcare). MecA (20 mM), ClpP (20 mM), casein (16.66 mM) and FITC-casein
(2.5 mM) were added as indicated. Experiments were run at 25˚C in buffer A (50 mM Tris pH 7.5, 25
mM KCl, 20 mM MgCl2) supplemented with 2 mM ATP. Samples were prepared freshly and incu-
bated for 5 min with 2 mM ATP prior to injection. Fractions were collected in 96-well plates, aliquots
taken and subjected to SDS-PAGE. Gels were stained using SYPRO Ruby Protein Gel Stain (Thermo-
Fisher) following manufacturer instructions. Band intensities were quantified using ImageJ. To moni-
tor the binding of ClpC to FITC-Casein, the collected fractions were analyzed for FITC fluorescence
using FLUOstar Omega (BMG Labtech) with standard FITC filter sets. Chromatography was per-
formed in three independent experiments each and representative results are provided.
Complex formation analyzed by SEC was additionally followed by online multi-angle light scatter-
ing (MALS) using an Agilent 1260 Infinity II HPLC system connected in series with a 3-angle multi-
angle light scattering detector (miniDAWN TREOS II, Wyatt Technology, collection rate of 2 data
points per second) and an additional online differential refractive index detector (Optilab T-rEX,
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Wyatt Technology) for concentration determination. Data analysis was performed using ASTRA 7.1
(Wyatt Technology). Samples were additionally filtered through a 0.2 mm low-protein binding syringe
filter (Millex-GV, Merck Millipore Ltd.) before application to the SEC-column.
ATPase activity
The ATPase rate of ClpC and mutants was determined using a coupled-colorimetric assay as
described before (Oguchi et al., 2012). The assay was carried out at 2 mM ATP in buffer A including
2 mM DTT at 30˚C using a FLUOstar Omega plate reader. The final protein concentrations were as
follows: ClpC (1 mM), MecA (1.5 mM), casein (10 mM). In presence of casein MecA concentrations
were reduced to 0.2 mM. The raw data was analyzed using the following equation:
ATPase rate¼
1
" NADHð Þ  c ATPaseð Þ d

d A340 nmð Þ
dt
" NADHð Þ: Extinction coefficient at 340 nm for NADH (M 1 cm 1)
c ATPaseð Þ: Concentration of ATPase (M)
d: path length (cm)
d A340 nmð Þdt: derivative of the linear graph (slope)
ATPase rates were calculated from the linear decrease of A340 in at least three independent
experiments and standard deviations were calculated.
Degradation assays
FITC-casein degradation was analyzed using a CLARIOstar plate reader, in black 384 well plates
(Corning, NBS coated, flat bottom), in buffer A with 2 mM DTT. The final protein concentrations
were as follows 0.3 mM FITC-casein, 1 mM ClpC, 1.5 mM MecA, 2 mM ClpP. The assay was carried
out in the presence of an ATP regenerating system (0.02 mg/mL PK, 3 mM PEP pH 7.5) and 2 mM
ATP. The increase of FITC-casein fluorescence upon its degradation was monitored by using 483
and 520/530 nm as excitation and emission wavelengths, respectively.. For data processing the
background in the absence of ClpC was subtracted and the initial fluorescence intensities were set
to 1. FITC-casein degradation rates were determined by the initial slopes of the fluorescence signal
increase in at least three independent experiments and standard deviations were calculated. Alterna-
tively degradation of FITC-casein (5 mM) was monitored by SDS-PAGE followed by Coomassie
staining.
Degradation of GFP-SsrA (0.2 mM) was performed in buffer A with 2 mM DTT using the following
protein concentrations: 1 mM ClpC, 1.5 mM MecA, 2 mM ClpP. Reactions were started by addition of
an ATP regenerating system (0.02 mg/mL PK, 3 mM PEP pH 7.5) and 2 mM ATP. GFP fluorescence
was monitored with a LS55 spectrofluorimeter (Perkin Elmer) or a CLARIOstar plate reader (using
black 384 well plates, corning, NBS coated, flat bottom) using 400 and 510 nm as excitation and
emission wavelengths. Degradation rates were determined by the initial slopes of fluorescence sig-
nal decrease in at least three independent experiments and standard deviations were calculated.
For FITC-casein and GFP-SsrA degradation under saturating conditions MecA and ClpP concen-
trations were increased to 2 and 4 mM, respectively.
Crosslinking
Glutaraldehyde crosslinking was performed by incubating 1 mM ClpC or ClpB buffer B (50 mM
HEPES, 25 mM KCL, 10 mM MgCl2, 2 mM DTT, pH 7.5) in absence or presence of 2 mM ATP/ATPgS
and 3 mM MecA at 25˚C for 15 min. Crosslinking was started by adding Glutaraldehyde (Sigma) to a
final concentration of 0.1%. Aliquots were taken at indicated time points and crosslinking was
quenched by adding Tris (pH 7.5) to a final concentration of 50 mM. Samples were subjected to
SDS-PAGE and gels stained with SYPRO Ruby Protein Gel Stain (ThermoFisher).
Disulfide crosslinking was performed by incubating 3 mM ClpC in buffer A (in the absence or pres-
ence of 2 mM nucleotide). MecA (4.5 mM) was added as indicated MecA and 2 mM b-Mercaptoetha-
nol at 25˚C for 5 min. Crosslinking was started by addition of copper-phenanthroline to a final
concentration of 100 mM. Aliquots were taken and crosslinking was stopped by adding SDS sample
buffer without b-mercaptoethanol but containing 4 mM iodacetamide. Samples were boiled and
analyzed by SDS-PAGE followed by Coomassie staining.
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Crosslinking was performed in two or more independent experiments each and representative
results are provided.
Anisotropy measurements
FITC-casein (100 nM) was incubated with varying concentrations ClpC in buffer A with 2 mM DTT for
1 hr in absence or presence of 2 mM ATPgS. Changes in fluorescence polarization were determined
using a CLARIOstar plate reader (BMG Labtech) at 482 and 530 nm excitation and emission wave-
lengths (Target mP 35).
Western blotting
SDS-PAGEs were transferred to nitrocellulose or PVDF membranes by semi-dry blotting or wet blot
transfer. Membranes were subsequently blocked with either 3% BSA (w/v) or 5% (w/v) skim milk
powder in TBS-T. Custom-made antibodies were used at the following dilutions: anti-ClpC (B. subti-
lis) 1:100.000, anti-ClpE 1:30.000, anti-ClpC (S. aureus) 1:50.000 and anti-MecA 1:30.000. anti-rabbit
alkaline phosphatase conjugate (Vector Laboratories) was used as secondary antibody (1:10.000).
Blots were developed using NBT/BCIP or ECF Substrate (GE Healthcare) as reagent and imaged via
Image-Reader LAS-4000 (Fujifilm). Western blotting was performed in two or more independent
experiments each and representative results are provided.
ClpC structure determination by cryo-electron microscopy
Cryo-electron microscopy
S. aureus ClpC WT (6 mM) was incubated for 15 min at room temperature in 25 mM Tris-HCl (pH
7.5), 25 mM KCl, 10 mM MgCl2, 1 mM DTT and 2 mM ATPgS. For ClpC-MecA complex formation,
S. aureus MecA was incubated with ClpC in a 3:1 molar ratio. Samples were vitrified with liquid eth-
ane on Quantifoil R2/2 grids using a Vitrobot Mark IV (FEI) at 100% humidity, 24˚C temperature and
blotting time of 3 s.
Images of ClpC were collected using the EPU software on a Titan Krios TEM (FEI) operating at
300kV, using a Falcon two direct electron detector (FEI). Images of ClpC in complex with MecA
were collected using the EPU software on a Titan Krios TEM (FEI) operating at 300kV equipped with
a Gatan K2 Summit direct electron detector and bioquantum energy filter with 20 eV slit. The defo-
cus range was set between  1 and  3 mm with a total dose of 30 electrons/A˚ (Doyle et al., 2013) in
17 frames for ClpC and 50 electrons/A˚ (Doyle et al., 2013) in 40 frames for ClpC-MecA. Pixel size
was 1.34 A˚/pixel for ClpC and 1.37 A˚/pixel for ClpC-MecA. The dose rate on the K2 camera was
4.125 e/pixel/sec and the exposure time 23 s.
Image processing
Movie frames alignment with dose weighting (Zheng et al., 2017) and CTF estimation (Rohou and
Grigorieff, 2015) was performed on-the-fly using a Scipion suite (de la Rosa-Trevı´n et al., 2016).
ClpC particles were picked with Gautomatch and a dataset of ~90.000 particles from 1100 micro-
graphs was generated. ClpC-MecA complex particles were picked using Gaussian picking in RELION
(Scheres, 2012) and ~500.000 particles from 2100 micrographs were obtained. The initial datasets
were subjected to reference-free 2D classification in order to clean the datasets.
Initially, for 3D processing of ClpC (Supplementary Figure 4), the crystal structure of ClpC-MecA
(Wang et al., 2011) low-pass filtered at 60 A˚ was used, but the dataset failed to refine. Attempts to
use ab initio models generated with Eman2 (Tang et al., 2007) also did not result in high-resolution
3D refinement. As the ClpC assembly appeared much larger in size than the ClpC-MecA hexamer,
we generated a cylindrical starting model by filtering to 70 A˚ two copies of ClpC-MecA stuck back
to back with the AAA2 rings in contact. With this starting model ClpC refined to 8.4 A˚ resolution as
estimated with the 0.143 FSC criterion, with visible separated helices. The same result was confirmed
by generating an ab-initio starting model using the SGD method implemented in cryoSPARC
(Punjani et al., 2017) and refining the structure within the same program suite. Reconstructions with
and without C2 symmetry applied were performed (Supplementary Figure 4, g-h) to a similar resolu-
tion and the C2 map was used for display as it allows a better visualization of N-domains.
For 3D processing of ClpC-MecA (Supplementary Figure 5) the crystal structure of the B. subtilis
ClpC-MecA complex filtered at 60 A˚ was used (pdb code: 3PXI). A large dataset was initially used,
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but particles were preferentially oriented so a reduced dataset (~26.000 particles) with balanced
angular distribution was used to reduce anisotropy. Both asymmetric and six fold symmetric maps
were built. Even though the nominal resolution of the symmetrized map was better, the reconstruc-
tion appeared over filtered, thus indicating that artifacts were caused by forced symmetrisation. The
final map was reconstructed at 11 A˚ resolution. Local resolution was evaluated using the local resolu-
tion tool of RELION.
Model building and fitting
The S. aureus atomic model of ClpC and MecA monomers were generated using Phyre2 (Kelley and
Sternberg, 2009). They were modelled based on the B. subtilis atomic structures (PDBcode: 3pxi).
Each protomer was rigidly fitted manually using USCFChimera (Pettersen et al., 2004) and refined
using iModFit (Lope´z-Blanco and Chaco´n, 2013). For the ClpC resting state structure, real-space
refinement in Phenix and Rosetta was performed trying to optimise as much as possible the model
geometry and giving less weight to the map. Flexible, non-fittable loops where cut away from the
final deposited pdb (PDBcode: 6EM9). Fittings were performed both on the C2 symmetrised and
asymmetric maps and both maps and C-a coordinates have been deposited (EMD-3895, EMDB-
3894). For the ClpC-MecA complex the S. aureus Phyre model was fitted into the map using Chi-
mera and refined with iMODfit. The ClpC-MecA map and the fitted pdb (only C-alpha) have been
deposited (PDBcode: 6EMW).
Analysis of AAA domain subunit interfaces was performed using PISA (http://www.ebi.ac.uk/
pdbe/pisa/picite.html).
Spot tests
E. coli cells harboring plasmid-encoded clpC alleles were grown in the absence of IPTG overnight at
30˚C. Serial dilutions were prepared, spotted on LB-plates containing different IPTG concentrations
and incubated for 24 hr at indicated temperatures. B. subtilis strains were inoculated with a fresh
overnight culture to an OD600 of 0.05 and grown to mid-exponential growth phase. Optical densities
of all strains were adjusted to OD600 of 1, serial dilutions were performed and 10 ml (10
 2 - 10 6)
were dropped on agar plates (without or with 100 mM IPTG) and incubated overnight at indicated
temperatures. Spot tests were performed in two or more independent experiments each and repre-
sentative results are provided.
Accession numbers
The EM maps have been deposited in the 3D-EM database (www.emdatabank.org) with accession
codes EMD-3895 (ClpC resting state C1), EMDB-3894 (ClpC resting state C2) and EMD-3897 (ClpC-
MecA). Half maps and masks have also been deposited. PDB models (including only C-a) based on
the EM maps have also been deposited with codes 6EM9 (ClpC resting state C1), 6EM8 (ClpC rest-
ing state C2) and 6EMW (ClpC-MecA).
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